Luigi Mangione, the accused in a high-profile murder case involving a healthcare CEO, is at the center of ongoing legal proceedings with significant media attention. A surprise federal hearing has been scheduled, raising speculation about potential plea deals as Mangione navigates pre-trial activities. Concerns regarding witness intimidation and harassment have led the presiding judge to rule that jurors in both his federal and state murder trials will remain anonymous. This decision aims to protect juror identities amidst fears that Mangione’s supporters may pose threats to those involved in the case. The upcoming trial is set to begin with jury selection on September 8, amidst intense scrutiny from the public and media, who are keen to understand the implications of this controversial case.